European Equities Traded in the US as American Depositary Receipts Rise Marginally in Friday Trading

MT Newswires Live00:17

European equities traded in the US as American depositary receipts were marginally higher late Friday morning, edging up 0.11% to 1,887.83 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by oil and gas company Eni (E) and healthcare tech conglomerate Philips (PHG), which rose 1% each. They were followed by brewing company Anheuser-Busch InBev (BUD) and consumer goods company Unilever (UL), which were up 1.3% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which fell 13% and 5.2% respectively. They were followed by telecommunications company Nokia (NOK) and accommodations booking site trivago (TRVG), which were down 4% and 0.3% respectively.

The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and alcoholic beverage company Diageo (DEO), which advanced 2.3% and 1.8% respectively. They were followed by medical device maker Smith & Nephew (SNN) and educational publisher Pearson (PSO), which increased 1.3% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and software firm Endava (DAVA), which lost 2.2% and 2% respectively. They were followed by mining company BHP Group (BHP), which dropped 2%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment